HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149,026 | +224.5% | 191,754 | +25.3% | 0.00% | – |
| Q4 2022 | $45,918 | -61.1% | 153,029 | -33.7% | 0.00% | – |
| Q3 2022 | $118,000 | +3.5% | 230,690 | +16.8% | 0.00% | – |
| Q2 2022 | $114,000 | -68.4% | 197,569 | -29.5% | 0.00% | – |
| Q1 2022 | $361,000 | -40.0% | 280,099 | -46.9% | 0.00% | – |
| Q4 2021 | $602,000 | -47.7% | 527,714 | -29.9% | 0.00% | – |
| Q3 2021 | $1,152,000 | -33.3% | 753,152 | -13.7% | 0.00% | – |
| Q2 2021 | $1,728,000 | -25.5% | 872,566 | -30.8% | 0.00% | – |
| Q1 2021 | $2,320,000 | +90.2% | 1,260,661 | +126.3% | 0.00% | – |
| Q4 2020 | $1,220,000 | +2159.3% | 557,064 | +3083.2% | 0.00% | – |
| Q3 2020 | $54,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |